European Commission approves lecanemab for treatment of early Alzheimer’s disease
European Commission approves lecanemab for treatment of early Alzheimer’s disease In a landmark decision, the European Commission has granted EU-wide authorisation for lecanemab, the first medicine to treat mild cognitive […]
AI-Mind Partners Present at Prestigious Alzheimer’s and Parkinson’s Conference in Vienna
AI-Mind Partners Present at Prestigious Alzheimer’s and Parkinson’s Conference in Vienna Partners from the AI-Mind project are proud to present new research findings this week at the International Conference on […]